bioRxivCancer Biology
TGF-beta promotes microtube formation in glioblastoma through Thrombospondin 1
J. V. Joseph, C. R. Magaut, S. Storevik, L. H. Geraldo, T. Mathivet, A. M. Latif, J. Rudewicz, J. Guyon, M. Gambaretti, F. Haukas, A. Trones, L. A. R. Ystaas, J. A. Hossain, S. Ninzima, W. Zhou, T. Tomar, B. Klink, L. Rane, B. K. Irving, J. Marrison, P. O Toole, H. Wurdak, J. Wang, Z. Di, F. Winkler, , H. Miletic
Abstract
Microtubes (MTs), cytoplasmic extensions of glioma cells, are important cell communication structures promoting invasion and treatment resistance through network formation. MTs are abundant in chemoresistant gliomas, in particular glioblastomas (GBMs), while they are uncommon in chemosensitive IDH-mutant and 1p/19q co-deleted oligodendrogliomas. To identify potential signaling pathways involved in MT formation we performed a bioinformatics analysis of TCGA data showing that the TGF-{beta} pathway is highly activated in GBMs compared to oligodendroglial tumors. In particular we observed that signaling pathways involved in extracellular matrix organization are differentially expressed between these tumor entities. Using patient-derived GBM stem cell lines, we demonstrated that TGF-{beta}1 stimulation promotes enhanced MT formation and communication via Calcium signaling. Inhibition of the TGF-{beta} pathway significantly reduced MT formation and its associated invasion in vitro and in vivo. Downstream of TGF-{beta}, we identified thrombospondin 1 (TSP1) as a potential mediator of MT formation in GBM through SMAD activation. TSP1 was upregulated upon TGF-{beta} stimulation and enhanced MT formation, which was inhibited by TSP1 shRNAs in vitro and in vivo. In conclusion, TGF-{beta} and its downstream mediator TSP1 are important mediators of the MT network in GBM and blocking this pathway could potentially help to break the complex MT driven invasion/ resistance network.
- organism: human
- assay: bulk RNA-seq
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- An engineered glioblastoma model yields novel macrophage-secreted drivers of invasion
E. A. Akins, D. Wilkins, … S. Kumar·bioRxiv·Nov 18, 2023
- TGFBR2-High mesenchymal glioma stem cells phenocopy regulatory T cells to suppress CD4+ and CD8+ T cell function
Amanda Johnson, Harmon Singh Khela, … John Laterra·bioRxiv·Jan 7, 2025
- Patient-derived Glioblastoma Stem cells transfer mitochondria through Tunneling Nanotubes in Tumor Organoids
G. PINTO, I. SAENZ DE SANTA MARIA, … C. ZURZOLO·bioRxiv·Nov 21, 2020
- Glioblastoma Drives Protease-Independent Extracellular Matrix Invasion of Microglia
Chia-Wen Chang, Ashwin A. Bale, … Brendan A.C. Harley·Materials Today BioPeer-reviewed·Jan 9, 2025
- Traction force dynamics during patient-derived glioblastoma neurosphere invasion in 3D Matrigel
Hyeje C. Sumajit, David Böhringer, … Jerome Irianto·bioRxiv·Oct 1, 2024
- LNX1 Modulates Notch1 Signaling to Promote Expansion of the Glioma Stem Cell Population During Temozolomide Therapy in Glioblastoma
A. U. Ahmed·bioRxiv·Sep 10, 2020